Glipizide/metformin HCl; 2.5mg/250mg, 2.5mg/500mg, 5mg/500mg; tabs. Adjunct to diet and exercise in type 2 diabetes, as initial therapy or as second-line therapy when response to a sulfonylurea or ...
STOCKHOLM--(BUSINESS WIRE)-- Bristol-Myers Squibb Company (NYSE: BMY) and AstraZeneca (NYSE: AZN) today announced results from a randomized, double-blind Phase 3 clinical study in adults with type 2 ...
SHANGHAI, China — The use of metformin significantly reduced the risk of cardiovascular events among diabetic patients with coronary artery disease when compared with the sulfonylurea glipizide, ...
Episodes of low blood sugar were less frequent in patients treated with dapagliflozin added to metformin than in patients treated with glipizide added to metformin In addition to sustained reductions ...
ONGLYZA 5 mg plus metformin also resulted in a significantly smaller rise per week in HbA1c from week 24 to week 52 compared to titrated glipizide plus metformin. Overall adverse events excluding ...
52-Week Phase 3 Study Found Investigational Drug Dapagliflozin Plus Metformin Similar to Glipizide Plus Metformin in Improving Glycosylated Hemoglobin (HbA1c) in Adults with Type 2 Diabetes Mellitus ...
Glipizide is an oral drug used to treat type 2 diabetes. It belongs to the sulfonylurea drug class, which also includes glimepiride Amaryl, glyburide Diabeta, Glynase, tolbutamide, and tolazamide. In ...
Aug 6 (Reuters) - Drugmakers Sanofi, Eli Lilly, Novo Nordisk and AstraZeneca must face a lawsuit from two health centers accusing them of conspiring... Aug 6 (Reuters) - Drugmakers Sanofi, Eli Lilly, ...
STOCKHOLM, September 24, 2010 /PRNewswire/ -- Bristol-Myers Squibb Company (NYSE: BMY) (http://www.bms.com) and AstraZeneca (NYSE: AZN) (http://www.astrazeneca-us.com ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback